Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.
Perhaps the most powerful aspect of CGM readings are using them in combination with an insulin pump to automate insulin ...
The needles get dull and start to struggle to pierce the skin ... For me, a luxury would be an insulin pump that delivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback